| answer text |
<p>In February 2023, the Department published the MedTech strategy which outlined
how we will work with key stakeholders, including technology developers and academia,
to ensure the health and social care system can reliably access safe, effective, and
innovative medical technologies. To accelerate the introduction of innovative medical
solutions, we are working with stakeholders at pace to implement solutions to streamline
and join-up the innovation adoption pathway, from providing clear signals to industry
on the innovation we need, to reforming regulation, comparative assessment, and with
clearer procurement pathways.</p><p> </p><p>In October 2023, the Government announced
£30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund
is supporting integrated care systems to invest in the latest technology to help cut
waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients.
Thanks to this fund, tens of thousands of patients at risk of kidney disease will
be able to get tested from the comfort of their own homes. In February 2024, the Government
announced eight innovative tech companies who will be supported to bring their devices
to market through the Innovative Devices Access Pathway (IDAP). One of the technologies
allows chemotherapy patients to self-test at home, using a finger-prick blood test,
for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive
behaviour therapy, and targeted physical activity in a personally customisable format
to help patients manage multiple sclerosis.</p>
|
|
